OMICS Publishing Group, the world leader for contributing its prominent scientific services by organizing more than 100 International Conferences across the World and managing 350 peer-reviewed open access journals in science, health, and technology. Furthermore, OMICS Group has been associated with 100 more International scientific and technological societies and associations. The potential support from these International societies harness strong network development with the scientific core. OMICS Group Meetings hosts presentations from eminent experts in all the relevant fields and conducts International Workshops and International Symposiums.
With the overwhelming success of previous annual Vaccines conferences, OMICS Group welcomes you to attend the 4th International Conference on Vaccines & Vaccination, during September 24-26, 2014 at Valencia, Spain.
Vaccines 2014 This meeting will be the latest in a series of successful annual vaccine meetings organized by the OMICS Group Meetings that seek to bring together vaccine stakeholders including academic researchers, public health clinicians, vaccine policy makers, corporate and vaccine manufacturers. In association with the Vaccines-2014 meeting there will be opportunities for those selected to present at the meeting to also publish a manuscript from their talk in the Journal of Vaccines and Vaccination or its sister publication Immunome Research..
Vaccines-2014 anticipates more than 600 thought provoking presentations and eminent Keynote lectures. The attending delegates include Editorial Board Members of featured OMICS Group Journals. This is an excellent opportunity for the participants from Universities, Institutes and other Private Organizations to interact with the World class Scientists and renowned speakers.
The scientific sessions of the Vaccines & Vaccination conference housing all the current research in vaccines & vaccination research. Polio Vaccine will focus regarding free polio vaccine world; Cancer Vaccine will focus on translating cancer biology research into novel oncology treatments. Cancer imaging; HIV/AIDS Vaccine Human clinical trial of SAV001 prophylactic HIV vaccine and a new strategy for the development of therapeutic HIV vaccine: HPV Vaccines HPV Testing in Histological Specimens; Biodefense Vaccine, Therapeutic Vaccine and more other related topics discussed in this prestigious scientific meeting. This forum enables a common platform for the participants to discuss their research in order to establish a scientific network between the academia and industry leads to foster collaboration and to evaluate the emerging issues, technologies and innovations leads to explore new possibilities and improving the existed opportunities.
OMICS Group Vaccines 2014 Scientific Conference is sponsored by Sanofi Pasteur, France; GenPhar Inc., USA and Vaccinogen Inc., USA. With the support of Local Organizing Committee and International Organizing Committee we anticpate more than 600 participants from all over the world.
Alexander von Gabain: "How to foster innovation to meet the global gap of novel vaccines: Leanings from the European Institute of Innovation and Techonolgy, EIT"
Nikolai Petrovsky: "Vaccine Adjuvants; the good, the bad and the ugly"
Michael G. Hanna: "The practical influence of tumor genomic heterogeneity on active specific immunotherapy"
Therapeutic vaccines for chronic infections
Vaccine antigen modeling
Immuno-informatics in vaccine design
Vaccine formulation issues
|Participants List from Academia|
|Participants List from Business|